AMST vs NVDA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMST exhibits severe financial distress despite strong revenue growth, as reflected in its critically low Piotroski F-Score of 1/9 and absence of an Altman Z-Score, indicating high bankruptcy risk. The company reports massive operating losses, negative ROE and ROA, and a gross margin that is artificially inflated by minimal cost structure, suggesting unsustainable profitability. While revenue growth is explosive at 746.8% YoY, it is not translating into earnings, and the stock trades at an extreme valuation (Price/Sales: 27.71) with no earnings support. The 52-week price range shows extreme volatility, and the 5-year return of -97.4% underscores long-term underperformance. Analyst coverage is absent, and insider activity is neutral, offering no conviction signal.
NVDA shows bullish fundamentals based on deterministic rules. Financial strength is strong (F-Score 7/9). Key strengths include strong valuation and growth metrics. Price trades at a 20.7% premium to fair value estimate ($144.55), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
AMST vs NVDA: Head-to-Head Comparison
This page compares Amesite Inc. (AMST) and NVIDIA Corporation (NVDA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.